We are live on ! Find out more

2,503 hedge funds and large institutions have $106B invested in Amgen in 2022 Q4 according to their latest regulatory filings, with 313 funds opening new positions, 849 increasing their positions, 1,005 reducing their positions, and 87 closing their positions.

New
Increased
Maintained
Reduced
Closed

260% more first-time investments, than exits

New positions opened: 313 | Existing positions closed: 87

16% more funds holding in top 10

Funds holding in top 10: 85 → 99 (+14)

8% more funds holding

Funds holding: 2,326 → 2,503 (+177)

2% more call options, than puts

Call options by funds: $1.45B | Put options by funds: $1.42B

0.96% less ownership

Funds ownership: 76.64% → 75.68% (-0.96%)

5% less capital inflows, than outflows

Capital inflows: $6.46B | Capital outflows: $6.78B

16% less repeat investments, than reductions

Existing positions increased: 849 | Existing positions reduced: 1,005

Holders
2,503
Holders Change
+177
Holders Change %
+7.61%
% of All Funds
40.08%
Holding in Top 10
99
Holding in Top 10 Change
+14
Holding in Top 10 Change %
+16.47%
% of All Funds
1.59%
New
313
Increased
849
Reduced
1,005
Closed
87
Calls
$1.45B
Puts
$1.42B
Net Calls
+$25.8M
Net Calls Change
+$218M

AMGN Hedge Fund Activity: Q4 2022 in Review

2,503 of the 6,245 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q4 2022, worth a combined $106B — up 15% from $92.5B a quarter earlier.

Buyers outnumbered sellers: 313 funds opened new AMGN positions and 87 closed out — a net gain of 226 holders — while 849 added to existing stakes and 1,005 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $609M. The largest seller was Goldman Sachs, cutting an estimated $1.68B.

  • 2,503 institutional investors held Amgen (AMGN) as of Q4 2022, up from 2,326 in Q3 2022.
  • Funds reported $106B of Amgen stock for Q4 2022, up 15% quarter-over-quarter.
  • 313 funds opened new Amgen positions in Q4 2022 and 87 closed out, a net change of +226 holders.
  • The largest Amgen buyer in Q4 2022 was JP Morgan Chase, an estimated $609M added.
  • The largest Amgen seller in Q4 2022 was Goldman Sachs, an estimated $1.68B sold.

Based on aggregated 13F filings for Q4 2022.